Page last updated: 2024-10-22

theophylline and Cardiovascular Diseases

theophylline has been researched along with Cardiovascular Diseases in 70 studies

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"Asthmatic patients receiving montelukast and, to some extent, low-dose theophylline have lower levels of CVD-associated inflammatory biomarkers and lipid levels."9.12The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. ( Allayee, H; Conti, DV; Hartiala, J; Irvin, CG; Lee, W; Lima, JJ; Mehrabian, M, 2007)
"Theophylline is a useful drug for the treatment of asthma."7.73A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. ( Adachi, M; Fukuda, T; Kihara, N; Makino, S; Miyamoto, T; Nakajima, S; Nishima, S; Ohta, K, 2006)
"Asthmatic patients receiving montelukast and, to some extent, low-dose theophylline have lower levels of CVD-associated inflammatory biomarkers and lipid levels."5.12The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. ( Allayee, H; Conti, DV; Hartiala, J; Irvin, CG; Lee, W; Lima, JJ; Mehrabian, M, 2007)
"Theophylline is a useful drug for the treatment of asthma."3.73A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. ( Adachi, M; Fukuda, T; Kihara, N; Makino, S; Miyamoto, T; Nakajima, S; Nishima, S; Ohta, K, 2006)
"Theophylline has long been a cornerstone of bronchodilator therapy for asthma and chronic obstructive lung disease, but until recently its use carried the risk of serious, even fatal, toxicity."3.67Theophylline therapy. Titrating dosage requirements. ( Uden, DL; Wyatt, RA; Zaske, DE, 1984)
"Some recent epidemiologic studies have reported a nonlinear dose-response in the relationship between coffee consumption and health risks, such that the risks increase disproportionately to the increase in dose."2.67Dose-dependency of caffeine metabolism with repeated dosing. ( Benowitz, NL; Brown, CR; Denaro, CP; Jacob, P; Wilson, M, 1990)
"Aminophylline therapy has undergone change in the past decade."2.37Aminophylline toxicity. ( Albert, S, 1987)
"Theophylline was the main drug prescribed to in-patients discharged from hospital, although inhaling beta 2-agonists were also recommended in few cases."1.30[Respiratory medicine in the aged. Therapeutic problemsd]. ( Cossi, S; De Martinis, M; Ghisla, MK; Grassi, V; Leonardi, R; Tomasi, MF, 1997)
"Although arrhythmias associated with myocardial infarction are managed primarily with drug therapy, those associated with acute respiratory failure respond best to adequate oxygenation and correction of metabolic and hemodynamic abnormalities."1.27Managing asthma and COPD in patients with cardiovascular disease. ( George, RB; Payne, DK, 1985)

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-199056 (80.00)18.7374
1990's4 (5.71)18.2507
2000's9 (12.86)29.6817
2010's1 (1.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, TA1
Pickard, AS1
Au, DH1
Bartle, B1
Weiss, KB1
Chen, Y1
Tu, JH1
He, YJ1
Zhang, W1
Wang, G1
Tan, ZR1
Zhou, G1
Fan, L1
Zhou, HH1
Schudt, C1
Hatzelmann, A1
Beume, R1
Tenor, H1
BERGER, F1
CELLI, L1
MUZIO, L1
BALZARINI, E1
HILLER, E1
THIESS, A1
OSBORN, DP1
SACHSSE, B1
BAMMELUND, E1
KAISER, R1
LINKE, H1
LANG, W1
PABST, HW1
SCHWALB, H1
HENSEL, H1
MULLER, R1
SCHILD, W1
ASCIONE, A2
VITALE, P2
LAMPRECHT, G1
BALDINI, L1
BRAMBILLA, G1
CAVALLINI, L1
BANSE, HJ1
ZAHNOW, W1
THURAU, H1
LANDEN, HC1
ARQUINT, A1
BLOECHLINGER, K1
BOGENMANN, E1
BARTOUSEK, V1
BRUCKNER, L1
CERNY, J1
DOLECEK, R1
EISLER, L1
FALK, G1
LERCHE, W1
HUNGER, H1
BROGLIA, F1
SPERLING, M1
MAU, G1
SCHENNETTEN, FP1
KUSZTOS, D1
HAFFNER, Z1
FEUSER, J1
LOOS, M1
WERKO, L1
LAGERLOF, H1
TARTARA, A1
McMICHAEL, J1
Makino, S1
Adachi, M1
Ohta, K1
Kihara, N1
Nakajima, S1
Nishima, S1
Fukuda, T1
Miyamoto, T1
Allayee, H1
Hartiala, J1
Lee, W1
Mehrabian, M1
Irvin, CG1
Conti, DV1
Lima, JJ1
Nishii, M1
Izumi, T1
Sanner, B1
Schäfer, T1
Uden, DL1
Wyatt, RA1
Zaske, DE1
Minton, NA1
Henry, JA1
Leonardi, R1
Cossi, S1
De Martinis, M1
Ghisla, MK1
Tomasi, MF1
Grassi, V1
Quinn, MJ1
Fitzgerald, DJ1
Hirooka, K1
Shimizu, M1
Mineshita, S1
Dini, FL1
Cogo, R1
Magazanik, NA1
Rhomberg, F1
Denaro, CP1
Brown, CR1
Wilson, M1
Jacob, P1
Benowitz, NL1
Sato, S1
Levy, G1
Stanley, R1
Comer, T1
Taylor, JL1
Saliba, D1
Sollevi, A1
Albert, S1
George, RB1
Payne, DK1
Schulz, FH1
Hapke, HJ2
Ruggerini, R1
Grugni, P1
Bolognesi, L1
Romitti, M1
Poggi, G1
Senini, G1
Inga, EF1
Duchêne-Marullaz, P1
Lavarenne, J1
Hartmann, K1
Van Schepdael, J1
Solvay, H1
Molino, N1
Belluardo, C1
Molino, S1
Bross, W1
Bross, T1
Kozuszek, W1
Olejak, B1
Kustrzycki, A1
Koltowski, R1
Meschino, S1
Meoni, S1
Massari, F1
Fontana, F1
Pelster, C1
Overbeck, P1
Bergsdorf, M1
Erfurth, HJ1
Görlich, N1
Neuffer, F1
Schotten, EW1
Spohd, H1
Zettel, G1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparative Effectiveness of COPD Assessment and Management Bundle Versus Usual Care in Patients Suspected of Having COPD[NCT01833026]56 participants (Actual)Interventional2013-03-31Completed
Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study)[NCT03137303]Phase 3402 participants (Actual)Interventional2017-07-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Accurate Classification of Irreversible Airflow Obstruction

accuracy of diagnosis was the outcome measure. The results of the spirometry test (done in the beginning for the intervention group and ant the end of 1 year for the usual care groups) were reviewed in conjunction with the initial physician diagnosis of COPD and/or asthma to confirm whether the diagnosis was accurate, not accurate, or indeterminate. Accuracy of diagnosis of COPD was determined by spirometry results if the FEV1/FVC ratio was <0.7. (NCT01833026)
Timeframe: spirometry was performed at the first visit for intervention group and at 1 year from recruitment for the usual care group, one time assessment for both groups

InterventionParticipants (Count of Participants)
COPD Assessment and Management Recommendations10
Usual Care5

Total Number of Healthcare Visits

Determine differences in healthcare visits which include all-cause and respiratory related, acute care outpatient visits, emergency department visits, and hospitalizations between groups (NCT03137303)
Timeframe: 1 year

InterventionParticipants (Count of Participants)
Emergency room visit72551318Emergency room visit72551317Hospitalization72551317Hospitalization72551318Acute outpatient visit72551318Acute outpatient visit72551317Routine primary care visits72551317Routine primary care visits72551318New diagnostic tests72551318New diagnostic tests72551317
NoMissingYes
Patient Subject Usual Care111
Patient-Subject Intervention76
Patient Subject Usual Care119
Patient-Subject Intervention93
Patient Subject Usual Care1
Patient Subject Usual Care48
Patient-Subject Intervention17
Patient Subject Usual Care182
Patient-Subject Intervention152
Patient Subject Usual Care61
Patient-Subject Intervention35
Patient Subject Usual Care169
Patient-Subject Intervention134
Patient Subject Usual Care198
Patient-Subject Intervention138
Patient Subject Usual Care32
Patient-Subject Intervention31
Patient-Subject Intervention2
Patient Subject Usual Care126
Patient-Subject Intervention72
Patient Subject Usual Care104
Patient-Subject Intervention97

Reviews

9 reviews available for theophylline and Cardiovascular Diseases

ArticleYear
Phosphodiesterase inhibitors: history of pharmacology.
    Handbook of experimental pharmacology, 2011, Issue:204

    Topics: Animals; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Humans; Nitric Oxide; Phosphodieste

2011
[Cardiotoxicity of non-cardiac drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

    Topics: Anthracyclines; Antineoplastic Agents; Cardiovascular Diseases; Ergotamine; Histamine H2 Antagonists

2007
[Central sleep apnea syndrome].
    Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:14

    Topics: Acetazolamide; Altitude Sickness; Anticonvulsants; Bronchodilator Agents; Cardiovascular Diseases; C

2008
Acute and chronic human toxicity of theophylline.
    Human & experimental toxicology, 1996, Volume: 15, Issue:6

    Topics: Bronchodilator Agents; Cardiovascular Diseases; Central Nervous System Diseases; Drug Monitoring; Ga

1996
Ticlopidine and clopidogrel.
    Circulation, 1999, Oct-12, Volume: 100, Issue:15

    Topics: Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Angina, Unstable; Aspirin; Bo

1999
Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
    Current medical research and opinion, 2001, Volume: 16, Issue:4

    Topics: Animals; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Drug Evaluati

2001
Cardiovascular effects of adenosine in man; possible clinical implications.
    Progress in neurobiology, 1986, Volume: 27, Issue:4

    Topics: Adenosine; Cardiovascular Diseases; Cardiovascular System; Humans; Hypoxia; Ischemia; Purines; Recep

1986
Aminophylline toxicity.
    Pediatric clinics of North America, 1987, Volume: 34, Issue:1

    Topics: Adolescent; Aminophylline; Cardiovascular Diseases; Child; Gastrointestinal Diseases; Humans; Kineti

1987
[Recent data on coronary dilators].
    Actualites pharmacologiques, 1968, Volume: 21

    Topics: Amino Alcohols; Aminophylline; Animals; Benzofurans; Cardiovascular Diseases; Cats; Coronary Disease

1968

Trials

2 trials available for theophylline and Cardiovascular Diseases

ArticleYear
The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics.
    Chest, 2007, Volume: 132, Issue:3

    Topics: Acetates; Adult; Anti-Asthmatic Agents; Asthma; Biomarkers; C-Reactive Protein; Cardiovascular Disea

2007
Dose-dependency of caffeine metabolism with repeated dosing.
    Clinical pharmacology and therapeutics, 1990, Volume: 48, Issue:3

    Topics: Adult; Caffeine; Cardiovascular Diseases; Coffee; Dose-Response Relationship, Drug; Female; Humans;

1990

Other Studies

59 other studies available for theophylline and Cardiovascular Diseases

ArticleYear
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
    Annals of internal medicine, 2008, Sep-16, Volume: 149, Issue:6

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov

2008
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
    Annals of internal medicine, 2008, Sep-16, Volume: 149, Issue:6

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov

2008
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
    Annals of internal medicine, 2008, Sep-16, Volume: 149, Issue:6

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov

2008
Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.
    Annals of internal medicine, 2008, Sep-16, Volume: 149, Issue:6

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and ov

2008
Praxinor: abuse and dependence.
    Prescrire international, 2009, Volume: 18, Issue:99

    Topics: Cardiovascular Diseases; Drug Combinations; Humans; Hypotension, Orthostatic; Substance-Related Diso

2009
Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
    Xenobiotica; the fate of foreign compounds in biological systems, 2009, Volume: 39, Issue:7

    Topics: Adolescent; Adult; Caffeine; Cardiovascular Diseases; Cytochrome P-450 CYP1A2; Enzyme Activation; Hu

2009
[Results with bilophyllin].
    Der Praktische Arzt, 1952, Jan-15, Volume: 6, Issue:56

    Topics: Bile Acids and Salts; Cardiovascular Diseases; Salts; Theophylline

1952
[Effect of 1,3-dimethylxanthine ethylendiamine on gastric secretion of hydrochloric acid in heart diseases].
    Folia cardiologica, 1952, Volume: 11, Issue:6

    Topics: Aminophylline; Cardiovascular Diseases; Gastric Juice; Heart Diseases; Hydrochloric Acid; Metabolic

1952
[Clinical and oscillographic studies on the activity of a new watersoluble theophylline derivative, DHT].
    Deutsche medizinische Wochenschrift (1946), 1953, Jan-02, Volume: 78, Issue:1

    Topics: Cardiovascular Diseases; Theophylline

1953
[Effect of theophylline preparation on blood circulation].
    Medizinische Klinik, 1953, Oct-09, Volume: 48, Issue:41

    Topics: Cardiovascular Diseases; Humans; Theophylline

1953
The use of buthoids (butaphyllamine suppositories) as adjuncts in the treatment of cardiovascular disease.
    The Ohio State medical journal, 1953, Volume: 49, Issue:10

    Topics: Cardiovascular Diseases; Pessaries; Suppositories; Theophylline

1953
[Therapy of cardiovascular disorders and hypertension with a new purine derivative].
    Deutsche medizinische Wochenschrift (1946), 1953, Nov-06, Volume: 78, Issue:45

    Topics: Cardiovascular Diseases; Humans; Hypertension; Purines; Theophylline

1953
[Experiences in the clinical application of oxyethyltheophylline (cordalin)].
    Medizinische Klinik, 1953, Nov-20, Volume: 48, Issue:47

    Topics: Cardiovascular Diseases; Humans; Theophylline

1953
[Study and experience report of aerosol therapy with theophylline derivatives].
    Munchener medizinische Wochenschrift (1950), 1954, Oct-15, Volume: 96, Issue:42

    Topics: Aerosols; Bronchi; Bronchial Diseases; Cardiovascular Diseases; Disease; Heart Diseases; Theophyllin

1954
[The mode of action and clinical significance of theophylline].
    Munchener medizinische Wochenschrift (1950), 1954, Nov-12, Volume: 96, Issue:46

    Topics: Cardiovascular Diseases; Kidney; Theophylline

1954
[The diuretic effects oxyethyl-theophylline].
    Munchener medizinische Wochenschrift (1950), 1954, Apr-02, Volume: 96, Issue:14

    Topics: Cardiovascular Diseases; Diuretics; Theophylline

1954
[On the treatment of acute cerebral and cardiac blood circulation disorders].
    Munchener medizinische Wochenschrift (1950), 1955, Aug-19, Volume: 97, Issue:33

    Topics: Brain; Cardiac Glycosides; Cardiovascular Diseases; Heart; Humans; Hypoxia; Theophylline

1955
[Therapy of circulatory disorders in epidemic hepatitis].
    Zeitschrift fur arztliche Fortbildung, 1956, Mar-01, Volume: 50, Issue:5

    Topics: Cardiovascular Diseases; Hepatitis; Hepatitis A; Hypotension; Theophylline

1956
[Clinicotherapeutic research on a new synthetic theophylline derivative].
    Minerva medica, 1956, Oct-24, Volume: 47, Issue:85

    Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline

1956
[Clinicotherapeutic research on a new synthetic theophylline derivative].
    Minerva medica, 1956, Oct-24, Volume: 47, Issue:85

    Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline

1956
[Clinicotherapeutic research on a new synthetic theophylline derivative].
    Minerva medica, 1956, Oct-24, Volume: 47, Issue:85

    Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline

1956
[Clinicotherapeutic research on a new synthetic theophylline derivative].
    Minerva medica, 1956, Oct-24, Volume: 47, Issue:85

    Topics: Asthma; Cardiovascular Diseases; Humans; Research; Theophylline

1956
[Clinical experiences with the new vasodilator permanil].
    Munchener medizinische Wochenschrift (1950), 1957, Jul-12, Volume: 99, Issue:28

    Topics: Adenosine; Cardiovascular Diseases; Theophylline; Tissue Extracts; Vasodilator Agents

1957
[Theophylline-sparteine-induced ventricular fibrillation in rat].
    Archivio italiano di scienze farmacologiche, 1957, Volume: 7, Issue:4

    Topics: Animals; Cardiovascular Diseases; Rats; Sparteine; Theophylline; Ventricular Fibrillation

1957
[Therapeutic activity of choline theophyllinate associated with papaverine trichlorohydroxyethyl-p-aminobenzoate].
    Minerva medica, 1958, Mar-07, Volume: 49, Issue:19

    Topics: Cardiovascular Diseases; Choline; Humans; Papaverine; para-Aminobenzoates; Theophylline

1958
[New medicinal treatment possibilities of angiopathy in diabetics with 3-(methyloxyethylamino)-2-oxyprophyltheophylline nicotinate (complamin)].
    Munchener medizinische Wochenschrift (1950), 1958, Dec-26, Volume: 100, Issue:52

    Topics: Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Niacin; Nicotinic Acids; Theophy

1958
[New and authenticated theories from the area of theophylline and strophanthin therapy].
    Medizinische Klinik, 1959, Mar-06, Volume: 54, Issue:10

    Topics: Cardiovascular Diseases; Humans; Strophanthins; Theophylline; Vasoconstrictor Agents; Vasodilator Ag

1959
[Adenosine in cardiovascular disorders].
    Die Medizinische, 1959, May-16, Volume: 4, Issue:20

    Topics: Adenosine; Cardiovascular Diseases; Theophylline

1959
[The treatment of circulation disorders of various origins with Thenucline].
    Praxis, 1960, Nov-03, Volume: 49

    Topics: Brain; Cardiovascular Diseases; Cardiovascular System; Nucleosides; Nucleotides; Theophylline

1960
[Therapy of brain circulatory disorders in chronic cor pulmonale].
    Wiener klinische Wochenschrift, 1961, Jul-21, Volume: 73

    Topics: Brain; Brain Diseases; Cardiovascular Diseases; Chronic Disease; Humans; Hypertension, Pulmonary; Pu

1961
[Clinical contribution to the treatment of peripheral circulation disorders with Complamine].
    Medizinische Monatsschrift, 1961, Volume: 15

    Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul

1961
[Clinical observations in the treatment of AV block with peripherin (Homburg)].
    Die Medizinische Welt, 1961, Aug-26, Volume: 34

    Topics: Atrioventricular Block; Cardiovascular Diseases; Diuretics; Ephedrine; Heart; Heart Block; Peripheri

1961
[Clinical experiences with soluble theophylline derivatives].
    Minerva medica, 1959, Oct-06, Volume: 50

    Topics: Cardiovascular Diseases; Humans; Theophylline

1959
[Clinical trial of the treatment of peripheral circulation disorders with Complamine].
    Munchener medizinische Wochenschrift (1950), 1962, Jul-06, Volume: 104

    Topics: Cardiovascular Diseases; Niacin; Nicotinic Acids; Peripheral Vascular Diseases; Theophylline; Vascul

1962
[Contribution to the therapy of blood circulation disorders and degenerative changes of the fundus oculi].
    Klinische Monatsblatter fur Augenheilkunde und fur augenarztliche Fortbildung, 1962, Volume: 141

    Topics: Cardiovascular Diseases; Fundus Oculi; Humans; Niacin; Nicotinic Acids; Optic Nerve; Retina; Theophy

1962
[HOW DOES THE HEPATOCARDIAL SYNDROME AFFECT THE CARDIOVASCULAR SYSTEM?WITH DIRECTIONS FOR DRUG AND DIET THERAPY].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1963, Volume: 18

    Topics: Cardiovascular Diseases; Cardiovascular System; Diet; Diet Therapy; Diuretics; Heart Failure; Hepati

1963
[USE OF PERIPHERIN-HOMBURG IN CIRCULATORY DISEASES OF THE BRAIN].
    Orvosi hetilap, 1964, May-24, Volume: 105

    Topics: Brain; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebrovascular Disorders; Ephedrine; Humans; I

1964
[A CONTRIBUTION TO COMPLAMIN TREATMENT].
    Therapie der Gegenwart, 1964, Volume: 103

    Topics: Arteriosclerosis Obliterans; Biomedical Research; Cardiovascular Diseases; Coronary Disease; Drug Th

1964
[ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
    Die Medizinische Welt, 1964, Aug-08, Volume: 32

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Drug Therapy; Niacin; Nicotinic Acids; Theophyll

1964
[THE ORAL USE OF PURE THEOPHYLLINE--CLINICAL EXPERIENCES WITH SOLOSIN].
    Der Landarzt, 1964, Jun-30, Volume: 40

    Topics: Administration, Oral; Biomedical Research; Cardiovascular Diseases; Drug Therapy; Theophylline

1964
Studies on the circulation of blood in man. VII. The effect of a single intravenous dose of theophylline diethanolamine on cardiac output, pulmonary blood volume and systemic and pulmonary blood pressures in hypertensive cardiovascular disease.
    Scandinavian journal of clinical and laboratory investigation, 1950, Volume: 2, Issue:3

    Topics: Blood Pressure; Blood Volume; Cardiac Output; Cardiovascular Diseases; Ethanolamines; Heart; Humans;

1950
[Therapeutic effect of theophylline acetic acid with sparteine (sparteine mono- and di-theophylline acetate)].
    Gazzetta medica italiana, 1951, Volume: 110, Issue:12

    Topics: Acetates; Acetic Acid; Cardiovascular Diseases; Humans; Sparteine; Theophylline

1951
The principle of venous pressure reduction in the treatment of heart failure.
    Modern concepts of cardiovascular disease, 1950, Volume: 19, Issue:6

    Topics: Blood Pressure; Cardiovascular Diseases; Digitalis; Digitalis Glycosides; Diuresis; Diuretics; Heart

1950
A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
    Allergology international : official journal of the Japanese Society of Allergology, 2006, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Anti-Asthmatic Agents; Asthma; Bronchiti

2006
Theophylline therapy. Titrating dosage requirements.
    Postgraduate medicine, 1984, Volume: 75, Issue:8

    Topics: Administration, Oral; Adolescent; Age Factors; Asthma; Cardiovascular Diseases; Child; Child, Presch

1984
[Respiratory medicine in the aged. Therapeutic problemsd].
    Recenti progressi in medicina, 1997, Volume: 88, Issue:12

    Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Anti-Bacterial Agents; A

1997
Theophylline metabolism after cardiac surgery.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:2

    Topics: Adult; Aminophylline; Cardiac Surgical Procedures; Cardiovascular Diseases; Cytochrome P-450 Enzyme

2001
[Disorders of bronchial patency and their treatment in circulatory insufficiency].
    Kardiologiia, 1977, Volume: 17, Issue:2

    Topics: Adrenal Cortex Hormones; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Blood Pressure; Bronch

1977
[General medical concepts for the dental treatment of aging patients].
    Schweizerische Monatsschrift fur Zahnheilkunde = Revue mensuelle suisse d'odonto-stomatologie, 1977, Volume: 87, Issue:9

    Topics: Aged; Aging; Asthma; Cardiovascular Diseases; Cortisone; Dietary Carbohydrates; Emergencies; Geriatr

1977
Systemic effect of ipecac on acute toxicity of phenobarbital and theophylline in rats.
    Fundamental and applied toxicology : official journal of the Society of Toxicology, 1989, Volume: 13, Issue:3

    Topics: Animals; Cardiovascular Diseases; Ipecac; Male; Nervous System Diseases; Phenobarbital; Rats; Rats,

1989
Mexiletine-theophylline interaction.
    The American journal of medicine, 1989, Volume: 86, Issue:6 Pt 1

    Topics: Aged; Amiodarone; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Interactions; Drug

1989
Managing asthma and COPD in patients with cardiovascular disease.
    Geriatrics, 1985, Volume: 40, Issue:7

    Topics: Adult; Aged; Arrhythmias, Cardiac; Asthma; Cardiovascular Diseases; Digitalis; Digitalis Glycosides;

1985
[Some problems of practical geriatrics].
    Zeitschrift fur Alternsforschung, 1974, Volume: 28, Issue:1

    Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Analgesics; Cardiovascular Diseases; Chemical and Dr

1974
[Management of heart and circulation. 1. Circulatory agents].
    Tierarztliche Praxis, 1973, Volume: 1, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Caffeine; Cardiovascular Diseases; Peptides; Theophylline; Va

1973
[The treatment of heart and circulatory disorders. 1. Circulatory drugs].
    Tierarztliche Praxis, 1973, Volume: 1, Issue:3

    Topics: Acridines; Angiotensin II; Animals; Blood Pressure; Caffeine; Cardiovascular Diseases; Cardiovascula

1973
[Clinical, anesthesiological and electroencephalographic findings in penthrane narcosis with and without hemokinetic treatment].
    Minerva anestesiologica, 1973, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Anesthesia; Cardiovascular Diseases; Cerebrovascular Circulation; Electroencephal

1973
[Results of the treatment of cardiovascular symptoms with Cardiopon].
    Zeitschrift fur Allgemeinmedizin, 1969, Jul-20, Volume: 45, Issue:20

    Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Female; Humans; Long-Term Care; Male; Middle Aged;

1969
[Clinical trial of diniprophylline-phenobarbital (Corverum) in oppressive cardio-respiratory disorders].
    Bruxelles medical, 1972, Volume: 52, Issue:9

    Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Drug Combinations; Dyspnea; Female; Humans;

1972
[The action of Teo-Caradrin in cardiovascular diseases. Our clinical experience].
    Minerva cardioangiologica, 1969, Volume: 17, Issue:11

    Topics: Aged; Cardiac Glycosides; Cardiovascular Diseases; Diuresis; Electrocardiography; Female; Heart; Hum

1969
Bronchodilators.
    British medical journal, 1970, Feb-14, Volume: 1, Issue:5693

    Topics: Alcohols; Aminophylline; Asthma; Bronchodilator Agents; Cardiovascular Diseases; Child; Child, Presc

1970
[Rheographic examination following cardiovascular surgery].
    Medizinische Klinik, 1970, Mar-27, Volume: 65, Issue:13

    Topics: Adult; Blood Volume; Cardiovascular Diseases; Collateral Circulation; Extremities; Female; Heart Val

1970
[Proscillaridine A in association with theophylline, ethylcrotylbarbituric acid and mecloxamine in clinical practice].
    Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica, 1967, Volume: 16, Issue:1

    Topics: Adult; Aged; Arrhythmias, Cardiac; Arteriosclerosis; Barbiturates; Cardiovascular Diseases; Coronary

1967
[Complamin Retard (Tika)].
    Lakartidningen, 1968, Jun-04, Volume: 65

    Topics: Cardiovascular Diseases; Chemical Phenomena; Chemistry; Nicotinic Acids; Theophylline

1968
[On the problem of stimulation of the blood circulation and blood coagulation. Studies on Akrinor].
    Munchener medizinische Wochenschrift (1950), 1969, Jan-24, Volume: 111, Issue:4

    Topics: Anticoagulants; Blood Coagulation; Cardiovascular Diseases; Coronary Disease; Ephedrine; Humans; Nor

1969
[Taking into account myocardial metabolism in minor heart therapy].
    Therapie der Gegenwart, 1965, Volume: 104, Issue:10

    Topics: Adult; Aged; Cardiovascular Diseases; Humans; Middle Aged; Myocardium; Plants, Medicinal; Theophylli

1965